- Home
- WSBCP vs GNLX Comparison
WSBCP vs GNLX Comparison
Compare WSBCP & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBCP
- GNLX
- Stock Information
- Founded
- WSBCP N/A
- GNLX 2001
- Country
- WSBCP United States
- GNLX United States
- Employees
- WSBCP 2321
- GNLX N/A
- Industry
- WSBCP Major Banks
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- WSBCP Finance
- GNLX Health Care
- Exchange
- WSBCP Nasdaq
- GNLX Nasdaq
- Market Cap
- WSBCP N/A
- GNLX 103.6M
- IPO Year
- WSBCP N/A
- GNLX 2023
- Fundamental
- Price
- WSBCP $25.15
- GNLX $2.27
- Analyst Decision
- WSBCP
- GNLX Strong Buy
- Analyst Count
- WSBCP 0
- GNLX 4
- Target Price
- WSBCP N/A
- GNLX $18.25
- AVG Volume (30 Days)
- WSBCP N/A
- GNLX 141.5K
- Earning Date
- WSBCP N/A
- GNLX 11-14-2024
- Dividend Yield
- WSBCP N/A
- GNLX N/A
- EPS Growth
- WSBCP N/A
- GNLX N/A
- EPS
- WSBCP N/A
- GNLX N/A
- Revenue
- WSBCP N/A
- GNLX $8,000.00
- Revenue This Year
- WSBCP N/A
- GNLX N/A
- Revenue Next Year
- WSBCP N/A
- GNLX N/A
- P/E Ratio
- WSBCP N/A
- GNLX N/A
- Revenue Growth
- WSBCP N/A
- GNLX N/A
- 52 Week Low
- WSBCP N/A
- GNLX $1.60
- 52 Week High
- WSBCP N/A
- GNLX $16.60
- Technical
- Relative Strength Index (RSI)
- WSBCP 46.01
- GNLX 38.68
- Support Level
- WSBCP $25.10
- GNLX $2.13
- Resistance Level
- WSBCP $25.29
- GNLX $2.80
- Average True Range (ATR)
- WSBCP 0.10
- GNLX 0.20
- MACD
- WSBCP -0.01
- GNLX -0.04
- Stochastic Oscillator
- WSBCP 19.23
- GNLX 14.21
About WSBCP WesBanco Inc. Depositary Shares Each Representing a 1/40th Interest in a Share of 6.75% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
Wesbanco Inc is a bank holding company that offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. The company has two reportable segments: community banking and trust and investment services. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. Its market service area primarily includes the Rust Belt region of the United States. Commercial real estate accounts for nearly half of the bank's loan portfolio. The bank has historically grown through both organic growth and acquisitions. The bank's primary component of net revenue is net interest income.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.